News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

John W. Skoug

Advertisement

Articles by John W. Skoug

Early Development GMPs for Drug-Product Manufacturing of Small Molecules: An Industry Perspective (Part III)

ByRichard Creekmore,Amnon Eylath,John W. Skoug,Jackson Pellett,Michael Lovdahl,Dennis Joiner,Eleni Dokou,Eric Schmitt
August 2nd 2012

IQ Consortium representatives explore industry approaches and practices for applying GMPs in early development.

GMPs for Small-Molecule Drugs in Early Development (Part I)

ByTony Mazzeo,Amnon Eylath,John W. Skoug,Brent Kleintop,Andy Rignall,James S. McElvain
June 2nd 2012

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.

Advertisement

Latest Updated Articles

  • Early Development GMPs for Drug-Product Manufacturing of Small Molecules: An Industry Perspective (Part III)
    Early Development GMPs for Drug-Product Manufacturing of Small Molecules: An Industry Perspective (Part III)

    Published: August 2nd 2012 | Updated:

  • GMPs for Small-Molecule Drugs in Early Development (Part I)
    GMPs for Small-Molecule Drugs in Early Development (Part I)

    Published: June 2nd 2012 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Sustainability and Stability in Excipients

2

CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development

3

Turning Real-World Data into Actionable Drug Development Insights With AI

4

Why Sound Science Is Pharma's Best Defense Against Regulatory Shifts

5

AI and Human Collaboration Essential for Bio/pharma Innovation

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us